91ÖĆƬł§

Published on Market Research Reports® Inc. ()

Home > Global AI-driven Peptide Drug Discovery Platform Market Growth (Status and Outlook) 2024-2030

Global AI-driven Peptide Drug Discovery Platform Market Growth (Status and Outlook) 2024-2030

Publication ID: 
LPI10249883
Publication Date: 
October 14, 2024
Pages: 
101
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

IT Services [2]
Software [3]
Computing & Electronics [4]
Description: 

AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.
The global AI-driven Peptide Drug Discovery Platform market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (publisher)' newest research report, the “AI-driven Peptide Drug Discovery Platform Industry Forecast” looks at past sales and reviews total world AI-driven Peptide Drug Discovery Platform sales in 2022, providing a comprehensive analysis by region and market sector of projected AI-driven Peptide Drug Discovery Platform sales for 2023 through 2029. With AI-driven Peptide Drug Discovery Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-driven Peptide Drug Discovery Platform industry.
This Insight Report provides a comprehensive analysis of the global AI-driven Peptide Drug Discovery Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-driven Peptide Drug Discovery Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-driven Peptide Drug Discovery Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-driven Peptide Drug Discovery Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-driven Peptide Drug Discovery Platform.
United States market for AI-driven Peptide Drug Discovery Platform is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for AI-driven Peptide Drug Discovery Platform is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for AI-driven Peptide Drug Discovery Platform is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key AI-driven Peptide Drug Discovery Platform players cover Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Fujitsu, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-driven Peptide Drug Discovery Platform market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cloud-based
Local Deployment
Segmentation by Application:
Scientific Research
Pharmaceuticals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Cloud-based
Local Deployment
Segmentation by Application:
Scientific Research
Pharmaceuticals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Peptilogics
Pepticom Ltd
Menten AI
GUBRA
Fujitsu
Creative Peptides
LIGHT – Lifescience Innovation Good Healthcare Technology
UCB SA
Tidetronbio
Syneron
Generate Biomedicines
Peplib

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI-driven Peptide Drug Discovery Platform Market Size 2019-2030
2.1.2 AI-driven Peptide Drug Discovery Platform Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for AI-driven Peptide Drug Discovery Platform by Country/Region, 2019, 2023 & 2030
2.2 AI-driven Peptide Drug Discovery Platform Segment by Type
2.2.1 Cloud-based
2.2.2 Local Deployment
2.3 AI-driven Peptide Drug Discovery Platform Market Size by Type
2.3.1 AI-driven Peptide Drug Discovery Platform Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI-driven Peptide Drug Discovery Platform Market Size Market Share by Type (2019-2024)
2.4 AI-driven Peptide Drug Discovery Platform Segment by Application
2.4.1 Scientific Research
2.4.2 Pharmaceuticals
2.5 AI-driven Peptide Drug Discovery Platform Market Size by Application
2.5.1 AI-driven Peptide Drug Discovery Platform Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI-driven Peptide Drug Discovery Platform Market Size Market Share by Application (2019-2024)
3 AI-driven Peptide Drug Discovery Platform Market Size by Player
3.1 AI-driven Peptide Drug Discovery Platform Market Size Market Share by Player
3.1.1 Global AI-driven Peptide Drug Discovery Platform Revenue by Player (2019-2024)
3.1.2 Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Player (2019-2024)
3.2 Global AI-driven Peptide Drug Discovery Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-driven Peptide Drug Discovery Platform by Region
4.1 AI-driven Peptide Drug Discovery Platform Market Size by Region (2019-2024)
4.2 Global AI-driven Peptide Drug Discovery Platform Annual Revenue by Country/Region (2019-2024)
4.3 Americas AI-driven Peptide Drug Discovery Platform Market Size Growth (2019-2024)
4.4 APAC AI-driven Peptide Drug Discovery Platform Market Size Growth (2019-2024)
4.5 Europe AI-driven Peptide Drug Discovery Platform Market Size Growth (2019-2024)
4.6 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size Growth (2019-2024)
5 Americas
5.1 Americas AI-driven Peptide Drug Discovery Platform Market Size by Country (2019-2024)
5.2 Americas AI-driven Peptide Drug Discovery Platform Market Size by Type (2019-2024)
5.3 Americas AI-driven Peptide Drug Discovery Platform Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-driven Peptide Drug Discovery Platform Market Size by Region (2019-2024)
6.2 APAC AI-driven Peptide Drug Discovery Platform Market Size by Type (2019-2024)
6.3 APAC AI-driven Peptide Drug Discovery Platform Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2019-2024)
7.2 Europe AI-driven Peptide Drug Discovery Platform Market Size by Type (2019-2024)
7.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform by Region (2019-2024)
8.2 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Type (2019-2024)
8.3 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI-driven Peptide Drug Discovery Platform Market Forecast
10.1 Global AI-driven Peptide Drug Discovery Platform Forecast by Region (2025-2030)
10.1.1 Global AI-driven Peptide Drug Discovery Platform Forecast by Region (2025-2030)
10.1.2 Americas AI-driven Peptide Drug Discovery Platform Forecast
10.1.3 APAC AI-driven Peptide Drug Discovery Platform Forecast
10.1.4 Europe AI-driven Peptide Drug Discovery Platform Forecast
10.1.5 Middle East & Africa AI-driven Peptide Drug Discovery Platform Forecast
10.2 Americas AI-driven Peptide Drug Discovery Platform Forecast by Country (2025-2030)
10.2.1 United States Market AI-driven Peptide Drug Discovery Platform Forecast
10.2.2 Canada Market AI-driven Peptide Drug Discovery Platform Forecast
10.2.3 Mexico Market AI-driven Peptide Drug Discovery Platform Forecast
10.2.4 Brazil Market AI-driven Peptide Drug Discovery Platform Forecast
10.3 APAC AI-driven Peptide Drug Discovery Platform Forecast by Region (2025-2030)
10.3.1 China AI-driven Peptide Drug Discovery Platform Market Forecast
10.3.2 Japan Market AI-driven Peptide Drug Discovery Platform Forecast
10.3.3 Korea Market AI-driven Peptide Drug Discovery Platform Forecast
10.3.4 Southeast Asia Market AI-driven Peptide Drug Discovery Platform Forecast
10.3.5 India Market AI-driven Peptide Drug Discovery Platform Forecast
10.3.6 Australia Market AI-driven Peptide Drug Discovery Platform Forecast
10.4 Europe AI-driven Peptide Drug Discovery Platform Forecast by Country (2025-2030)
10.4.1 Germany Market AI-driven Peptide Drug Discovery Platform Forecast
10.4.2 France Market AI-driven Peptide Drug Discovery Platform Forecast
10.4.3 UK Market AI-driven Peptide Drug Discovery Platform Forecast
10.4.4 Italy Market AI-driven Peptide Drug Discovery Platform Forecast
10.4.5 Russia Market AI-driven Peptide Drug Discovery Platform Forecast
10.5 Middle East & Africa AI-driven Peptide Drug Discovery Platform Forecast by Region (2025-2030)
10.5.1 Egypt Market AI-driven Peptide Drug Discovery Platform Forecast
10.5.2 South Africa Market AI-driven Peptide Drug Discovery Platform Forecast
10.5.3 Israel Market AI-driven Peptide Drug Discovery Platform Forecast
10.5.4 Turkey Market AI-driven Peptide Drug Discovery Platform Forecast
10.6 Global AI-driven Peptide Drug Discovery Platform Forecast by Type (2025-2030)
10.7 Global AI-driven Peptide Drug Discovery Platform Forecast by Application (2025-2030)
10.7.1 GCC Countries Market AI-driven Peptide Drug Discovery Platform Forecast
11 Key Players Analysis
11.1 Peptilogics
11.1.1 Peptilogics Company Information
11.1.2 Peptilogics AI-driven Peptide Drug Discovery Platform Product Offered
11.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Peptilogics Main Business Overview
11.1.5 Peptilogics Latest Developments
11.2 Pepticom Ltd
11.2.1 Pepticom Ltd Company Information
11.2.2 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Offered
11.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pepticom Ltd Main Business Overview
11.2.5 Pepticom Ltd Latest Developments
11.3 Menten AI
11.3.1 Menten AI Company Information
11.3.2 Menten AI AI-driven Peptide Drug Discovery Platform Product Offered
11.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Menten AI Main Business Overview
11.3.5 Menten AI Latest Developments
11.4 GUBRA
11.4.1 GUBRA Company Information
11.4.2 GUBRA AI-driven Peptide Drug Discovery Platform Product Offered
11.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GUBRA Main Business Overview
11.4.5 GUBRA Latest Developments
11.5 Fujitsu
11.5.1 Fujitsu Company Information
11.5.2 Fujitsu AI-driven Peptide Drug Discovery Platform Product Offered
11.5.3 Fujitsu AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Fujitsu Main Business Overview
11.5.5 Fujitsu Latest Developments
11.6 Creative Peptides
11.6.1 Creative Peptides Company Information
11.6.2 Creative Peptides AI-driven Peptide Drug Discovery Platform Product Offered
11.6.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Creative Peptides Main Business Overview
11.6.5 Creative Peptides Latest Developments
11.7 LIGHT – Lifescience Innovation Good Healthcare Technology
11.7.1 LIGHT – Lifescience Innovation Good Healthcare Technology Company Information
11.7.2 LIGHT – Lifescience Innovation Good Healthcare Technology AI-driven Peptide Drug Discovery Platform Product Offered
11.7.3 LIGHT – Lifescience Innovation Good Healthcare Technology AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 LIGHT – Lifescience Innovation Good Healthcare Technology Main Business Overview
11.7.5 LIGHT – Lifescience Innovation Good Healthcare Technology Latest Developments
11.8 UCB SA
11.8.1 UCB SA Company Information
11.8.2 UCB SA AI-driven Peptide Drug Discovery Platform Product Offered
11.8.3 UCB SA AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 UCB SA Main Business Overview
11.8.5 UCB SA Latest Developments
11.9 Tidetronbio
11.9.1 Tidetronbio Company Information
11.9.2 Tidetronbio AI-driven Peptide Drug Discovery Platform Product Offered
11.9.3 Tidetronbio AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Tidetronbio Main Business Overview
11.9.5 Tidetronbio Latest Developments
11.10 Syneron
11.10.1 Syneron Company Information
11.10.2 Syneron AI-driven Peptide Drug Discovery Platform Product Offered
11.10.3 Syneron AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Syneron Main Business Overview
11.10.5 Syneron Latest Developments
11.11 Generate Biomedicines
11.11.1 Generate Biomedicines Company Information
11.11.2 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Offered
11.11.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Generate Biomedicines Main Business Overview
11.11.5 Generate Biomedicines Latest Developments
11.12 Peplib
11.12.1 Peplib Company Information
11.12.2 Peplib AI-driven Peptide Drug Discovery Platform Product Offered
11.12.3 Peplib AI-driven Peptide Drug Discovery Platform Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Peplib Main Business Overview
11.12.5 Peplib Latest Developments
12 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-ai-driven-peptide-drug-discovery-platform-market-growth-status-and-outlook-2024-2030

Links
[1] /countries/global[2] /it-services[3] /software[4] /computing-electronics